CONMED Corporation
CNMD
$57.08
-$0.67-1.16%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.04M | 33.76M | 48.98M | 29.98M | 19.71M |
| Total Depreciation and Amortization | 18.25M | 16.61M | 17.97M | 17.84M | 18.04M |
| Total Amortization of Deferred Charges | 1.44M | 2.84M | 1.44M | 1.41M | 1.41M |
| Total Other Non-Cash Items | 15.17M | 14.02M | -18.41M | -459.00K | 1.56M |
| Change in Net Operating Assets | 636.00K | -23.88M | 1.21M | -5.46M | -11.59M |
| Cash from Operations | 41.53M | 43.34M | 51.20M | 43.31M | 29.12M |
| Capital Expenditure | -3.78M | -4.04M | -3.42M | -3.59M | -2.04M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 850.00K | -- | -- | -- | -- |
| Cash from Investing | -2.93M | -4.04M | -3.42M | -3.59M | -2.04M |
| Total Debt Issued | 166.00M | 150.00M | 143.00M | 204.00M | 254.00M |
| Total Debt Repaid | -180.59M | -186.00M | -169.00M | -230.00M | -238.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.18M | -6.18M | -6.16M | -6.16M | -6.15M |
| Other Financing Activities | -7.63M | -8.89M | -6.67M | -11.93M | -26.86M |
| Cash from Financing | -28.40M | -51.07M | -38.83M | -44.09M | -17.01M |
| Foreign Exchange rate Adjustments | 819.00K | -2.24M | 645.00K | -617.00K | -513.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.03M | -14.01M | 9.60M | -4.99M | 9.56M |